Hu P, Steingrimsson J, Cole E, Cormack J, Dunn B, Gatsonis C
J Natl Cancer Inst Monogr. 2025; 2025(68):42-48.
PMID: 39989037
PMC: 11848039.
DOI: 10.1093/jncimonographs/lgae049.
Jabakhanji S, Valentelyte G, Manke-Reimers F, Halsteinli V, Odegard R, Martin A
Appl Health Econ Health Policy. 2025; 23(2):161-169.
PMID: 39893334
PMC: 11811246.
DOI: 10.1007/s40258-025-00946-z.
Lu H, Li F, Lesko C, Fink D, Rudolph K, Harhay M
Int J Epidemiol. 2025; 54(1).
PMID: 39868475
PMC: 11769716.
DOI: 10.1093/ije/dyaf003.
Ma Y, Pinzon M, Buckingham W, Bersch A, Powell W, LeCaire T
Alzheimers Dement (N Y). 2025; 11(1):e70036.
PMID: 39822591
PMC: 11736623.
DOI: 10.1002/trc2.70036.
Zivich P, Edwards J, Shook-Sa B, Lofgren E, Lessler J, Cole S
J R Stat Soc Ser A Stat Soc. 2025; 188(1):158-180.
PMID: 39810877
PMC: 11728055.
DOI: 10.1093/jrsssa/qnae084.
Use of transportability methods for real-world evidence generation: a review of current applications.
Levy N, Arena P, Jemielita T, Mt-Isa S, McElwee S, Lenis D
J Comp Eff Res. 2024; 13(11):e240064.
PMID: 39364567
PMC: 11542082.
DOI: 10.57264/cer-2024-0064.
Optimizing personalized treatments for targeted patient populations across multiple domains.
Chen Y, Zeng D, Wang Y
Int J Biostat. 2024; 20(2):437-453.
PMID: 39322995
PMC: 11661560.
DOI: 10.1515/ijb-2024-0068.
Generalizability in real-world trials.
Naher A, Kopka M, Balzer F, Schulte-Althoff M
Clin Transl Sci. 2024; 17(7):e13886.
PMID: 39046315
PMC: 11267629.
DOI: 10.1111/cts.13886.
Estimating the Effects of Cancer Screening in Clinical Practice Settings: The Role of Selective Uptake and Suboptimal Adherence along the Cancer Screening Continuum.
Lund J, Rivera M, Su I, Long J, Chen X, Pak J
Cancer Epidemiol Biomarkers Prev. 2024; 33(8):984-988.
PMID: 39012954
PMC: 11351907.
DOI: 10.1158/1055-9965.EPI-23-1491.
Identifying target populations to align with decision-makers' needs.
Lund J, Matthews A
Am J Epidemiol. 2024; 193(11):1503-1506.
PMID: 38897981
PMC: 11538562.
DOI: 10.1093/aje/kwae129.
Learning about treatment effects in a new target population under transportability assumptions for relative effect measures.
Dahabreh I, Robertson S, Steingrimsson J
Eur J Epidemiol. 2024; 39(9):957-965.
PMID: 38724763
PMC: 11663256.
DOI: 10.1007/s10654-023-01067-4.
Variable selection when estimating effects in external target populations.
Webster-Clark M, Ross R, Keil A, Platt R
Am J Epidemiol. 2024; 193(8):1176-1181.
PMID: 38629587
PMC: 11299018.
DOI: 10.1093/aje/kwae048.
Population Neuroscience: Understanding Concepts of Generalizability and Transportability and Their Application to Improving the Public's Health.
Keyes K, Pakserian D, Rudolph K, Salum G, Stuart E
Curr Top Behav Neurosci. 2024; 68:37-51.
PMID: 38589636
DOI: 10.1007/7854_2024_465.
Accommodating time-varying heterogeneity in risk estimation under the Cox model: a transfer learning approach.
Li Z, Shen Y, Ning J
J Am Stat Assoc. 2024; 118(544):2276-2287.
PMID: 38505403
PMC: 10950074.
DOI: 10.1080/01621459.2023.2210336.
Invited Commentary: Combining Information to Answer Epidemiologic Questions About a Target Population.
Dahabreh I
Am J Epidemiol. 2024; 193(5):741-750.
PMID: 38456780
PMC: 11484648.
DOI: 10.1093/aje/kwad014.
Standardizing to specific target populations in distributed networks and multisite pharmacoepidemiologic studies.
Webster-Clark M, Filion K, Platt R
Am J Epidemiol. 2024; 193(7):1031-1039.
PMID: 38412261
PMC: 11520739.
DOI: 10.1093/aje/kwae015.
Model-based standardization using multiple imputation.
Remiro-Azocar A, Heath A, Baio G
BMC Med Res Methodol. 2024; 24(1):32.
PMID: 38341552
PMC: 10858574.
DOI: 10.1186/s12874-024-02157-x.
Visualizing External Validity: Graphical Displays to Inform the Extension of Treatment Effects from Trials to Clinical Practice.
Lund J, Webster-Clark M, Westreich D, Sanoff H, Robert N, Frytak J
Epidemiology. 2024; 35(2):241-251.
PMID: 38290143
PMC: 10826920.
DOI: 10.1097/EDE.0000000000001694.
Transportability Analysis-A Tool for Extending Trial Results to a Representative Target Population.
Inoue K, Hsu W
JAMA Netw Open. 2024; 7(1):e2346302.
PMID: 38289608
PMC: 11167697.
DOI: 10.1001/jamanetworkopen.2023.46302.
Comparing Lung Cancer Screening Strategies in a Nationally Representative US Population Using Transportability Methods for the National Lung Cancer Screening Trial.
Robertson S, Joyce N, Steingrimsson J, Stuart E, Aberle D, Gatsonis C
JAMA Netw Open. 2024; 7(1):e2346295.
PMID: 38289605
PMC: 10828917.
DOI: 10.1001/jamanetworkopen.2023.46295.